Protecting communities from arsenic-related diseases
Core A: Administrative Core
This study is all about finding ways to protect people from health problems caused by arsenic in drinking water, especially those at risk for diabetes, by using special mouse models to learn more about how arsenic affects health and working closely with communities to make sure their needs are met.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10939015 on NIH RePORTER |
What this research studies
This research focuses on coordinating efforts to protect vulnerable populations from diseases caused by arsenic exposure. It involves planning and overseeing various projects that study the effects of arsenic on health, particularly in relation to diabetes and water contamination. The research utilizes humanized mouse models to understand susceptibility to arsenic-induced conditions and develops methods to predict and remove arsenic from drinking water. Community engagement is a key component, ensuring that the research is responsive to the needs of affected populations.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals living in areas with known arsenic contamination or those at risk of arsenic-related health issues.
Not a fit: Patients who are not exposed to arsenic or do not live in affected communities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for communities affected by arsenic exposure.
How similar studies have performed: Previous research has shown success in addressing arsenic contamination and its health effects, indicating that this approach has potential for meaningful impact.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Fry, Rebecca — Univ of North Carolina Chapel Hill
- Study coordinator: Fry, Rebecca
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.